- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00772252
Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment
Background: In patients undergoing hemodialysis or hemofiltration will suffer from the injury of reactive oxidative species. Oxidative stress will affect cell membrane, protein, and DNA. It will damage the cell and result in organ dysfunction. We believe that in patients, who have acute hepatic failure, undergoing plasma exchange or Molecular Absorbent Recirculating System for bridge therapy will suffer from the injury of reactive oxidative species, too. It will damage the kidney, lung, cerebral cortex, and other organs. It may result in death before the recovery of liver function or undergoing liver transplantation.
Aims: 1. Investigate the severity of oxidative stress and risk factors of high oxidative stress in acute hepatic failure patient undergoing plasma exchange or Molecular Absorbent Recirculating System. 2. Investigate the microcirculation status and risk factors in acute hepatic failure patient undergoing plasma exchange or Molecular Absorbent Recirculating System. 3. Study the relationship between oxidative stress and microcirculation status. 4. Study the correlation between oxidative stress and prognosis. 5. Study the correlation between microcirculation status and prognosis.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Yu-Chang Yeh
- Phone Number: 0968661829
- Email: tonyyeh@ntuh.gov.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Yu-Chang Yeh, bachelor
- Phone Number: 886-9-68661829
- Email: tonyyeh@ntuh.gov.tw
-
Principal Investigator:
- Yu-Chang Yeh, Bachelor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age > 18 years old
- Patients with acute deterioration on Chronic liver failure, who required liver support treamtment
- Patients with acute liver failure due to acute hepatitis, who reauired liver support treatment
- Patients with acute liver dysfunction within 7 days after liver transplantation, who required liver support treatment
Exclusion Criteria:
- Age > 70 years old
- Cancer, not curable
- Patients who had used of antioxidant therapy within 24 hours before study
- Patients who had received hyperbaric oxygen therapy within 24 hours before study
- Patients who had received peroxide treatment within 24 hours before study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
patient with hepatic failure undergoing liver support treatment in surgical intensive care unit
|
plasma exchange for liver support treatment
|
Collaborators and Investigators
Investigators
- Study Director: Yu-Chang Yeh, Bacehlor, Department of Anesthesiology, NTUH
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200806004R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Failure
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver FailureIndia
-
Beijing Continent Pharmaceutical Co, Ltd.RecruitingAcute-On-Chronic Liver Failure | Acute Liver FailureChina
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver Failure | Acute on Chronic Liver FailureIndia
-
Tianjin Weikai Bioeng., Ltd.Tianjin Nankai HospitalUnknownLiver Failure, Acute on ChronicChina
-
HLB Cell Co., Ltd.UnknownAcute-On-Chronic Liver Failure | Acute Liver FailureKorea, Republic of
-
Nanfang Hospital of Southern Medical UniversityCompletedLiver Injury | Liver Failure, Acute on Chronic
-
Third Affiliated Hospital, Sun Yat-Sen UniversityWithdrawnAcute-On-Chronic Liver Failure | Acute Liver FailureChina
-
RenJi HospitalNot yet recruiting
-
RenJi HospitalShanghai Institute of Biochemistry and Cell BiologyNot yet recruitingAcute-On-Chronic Liver Failure | Chronic Liver Failure
-
Institute of Liver and Biliary Sciences, IndiaRecruitingAcute on Chronic Liver FailureIndia
Clinical Trials on liver support treatment
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingAcute-On-Chronic Liver Failure | Hepatitis B, Chronic | ThrombocytopeniaChina
-
Vital Therapies, Inc.TerminatedSevere Acute Alcoholic HepatitisUnited States, Spain, United Kingdom, Germany
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingAcute-On-Chronic Liver Failure | Hepatitis B, ChronicChina
-
Third Affiliated Hospital, Sun Yat-Sen UniversityUnknownLiver Failure | Wilson DiseaseChina
-
National Blood Center Foundation, HemolifeUnknownInfections, CoronavirusColombia
-
Karolinska University HospitalCompletedPost Hepatectomy Liver FailureSweden
-
Universitätsklinikum Hamburg-EppendorfUniversity of UlmActive, not recruitingSevere Mental Health Condition With Indication of Hospital AdmissionGermany
-
Linkoeping UniversityCompletedGeneralized Anxiety DisorderSweden
-
Karolinska InstitutetHanoi Medical UniversityUnknownHuman Immunodeficiency Virus (HIV)Vietnam
-
Baxter Healthcare CorporationGambro Lundia AB; 2ConduCT; G.E.M. mbh Meerbusch; DatInfCompletedLiver FailureSpain, Denmark, Germany, Austria, France, Belgium, Italy, Switzerland, United Kingdom